Industrial and environmental biotechnologies

From the development of environmentally friendly materials to the decontamination of soil, air, and water, biotechnology is contributing to a cleaner, more cost-effective world.

  • Biobased production
  • Biocatalysis
  • Biomaterials and biobased chemicals
  • Bioprocessing in biomanufacturing
  • Bioremediation and waste treatment
  • Green chemistry
Submit an abstract

Track chair

Nathalie Garçon
CEO and CSO
BIOASTER

Nathalie Garçon biography

Nathalie Garçon, PharmD, PhD is currently the CEO and CSO of BIOASTER, the French research and technology institute for infectiology and microbiology. Dr. Garçon directs the scientific aspects of the institute with the objective of accelerating access to new technologies in infectious diseases that patient can benefit from.

Dr. Garçon holds two PhDs, one in biological pharmacy and the other in immunotoxicology and immunopharmacology. She worked on liposomes in vaccines as a postdoctoral research fellow at the Royal Free Hospital in London, and at the Baylor College of Medicine in Houston, Texas, as a postdoctoral research fellow and an assistant professor focused on vaccine delivery systems and immunopotentiators. Dr Garçon then joined SmithKline Beecham Biologicals, now GlaxoSmithKline vaccines, where she set up and led the Vaccine adjuvant and formulation group. At GSK, she held positions of increasing responsibility up to Vice-president, Adjuvants and technologies innovation centre.

Date modified: